Ahmed HI, Abdel-Sattar SA, Zaky HS (2018) Vinpocetine halts ketamine-induced schizophrenia-like deficits in rats: impact on BDNF and GSK-3β/β-catenin pathway. Naunyn Schmiedebergs Arch Pharmacol. https://doi.org/10.1007/s00210-018-1552-y
Beutler E, Duron O, Kelly BM (1963) Beutler E, Duron 0 & Kelly B M. Improved method for the determination of blood glutathione. J Lab Clin Med 61:882–888
Bian SZ, Liu WL, Zhang ZX et al (2009) The correlation between ketamine-induced schizophrenia-like signs in mice and the expressions of NRG1, ErbB4 mRNA. J Forensic Med. https://doi.org/10.3969/j.issn.1004-5619.2009.05.009
Bolton MM, Heaney CF, Sabbagh JJ et al (2012) Deficits in emotional learning and memory in an animal model of schizophrenia. Behav Brain Res. https://doi.org/10.1016/j.bbr.2012.04.049
Article PubMed PubMed Central Google Scholar
Bouayed J, Rammal H, Soulimani R (2009) Oxidative stress and anxiety relationship and cellular pathways. Oxid Med Cell Longev 2(2):63–7
Boultadakis A, Pitsikas N (2010) Effects of the nitric oxide synthase inhibitor L-NAME on recognition and spatial memory deficits produced by different NMDA receptor antagonists in the rat. Neuropsychopharmacology. https://doi.org/10.1038/npp.2010.109
Article PubMed PubMed Central Google Scholar
Buonanno A (2010) The neuregulin signaling pathway and schizophrenia: From genes to synapses and neural circuits. Brain Res Bull 83(3–4):122–131
Carli M, Calcagno E, Mainolfi P et al (2011) Effects of aripiprazole, olanzapine, and haloperidol in a model of cognitive deficit of schizophrenia in rats: Relationship with glutamate release in the medial prefrontal cortex. Psychopharmacology. https://doi.org/10.1007/s00213-010-2065-7
Cavoy A, Delacour J (1993) Spatial but not object recognition is impaired by aging in rats. Physiol Behav. https://doi.org/10.1016/0031-9384(93)90148-9
Chadha R, Meador-Woodruff JH (2020) Downregulated AKT-mTOR signaling pathway proteins in dorsolateral prefrontal cortex in Schizophrenia. Neuropsychopharmacol 45:1059–1067. https://doi.org/10.1038/s41386-020-0614-2
Chatterjee M, Ganguly S, Srivastava M, Palit G (2011) Effect of ‘chronic’ versus ‘acute’ ketamine administration and its ‘withdrawal’ effect on behavioural alterations in mice: Implications for experimental psychosis. Behav Brain Res. https://doi.org/10.1016/j.bbr.2010.08.001
Chatterjee M, Verma R, Kumari R et al (2015) Antipsychotic activity of standardized Bacopa extract against ketamine-induced experimental psychosis in mice: Evidence for the involvement of dopaminergic, serotonergic, and cholinergic systems. Pharm Biol. https://doi.org/10.3109/13880209.2014.976350
Che Y, Wang JF, Shao L, Young LT (2010) Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. J Psychiatry Neurosci 35(5):296–302
Chindo BA, Adzu B, Yahaya TA, Gamaniel KS (2012) Ketamine-enhanced immobility in forced swim test: a possible animal model for the negative symptoms of schizophrenia. Prog Neuro-Psychopharmacology Biol Psychiatry. https://doi.org/10.1016/j.pnpbp.2012.04.018
Chong VZ, Thompson M, Beltaifa S et al (2008) Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophr Res. https://doi.org/10.1016/j.schres.2007.12.474
Article PubMed PubMed Central Google Scholar
Chung DW, Chung Y, Bazmi HH, Lewis DA (2018) Altered ErbB4 splicing and cortical parvalbumin interneuron dysfunction in schizophrenia and mood disorders. Neuropsychopharmacology. https://doi.org/10.1038/s41386-018-0169-7
Article PubMed PubMed Central Google Scholar
de Oliveira L, Cecília CM, Bortolin T et al (2009) Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats. Prog Neuro-Psychopharmacol Biol Psychiatry. https://doi.org/10.1016/j.pnpbp.2009.05.010
Deakin IH, Law AJ, Oliver PL et al (2009) Behavioural characterization of neuregulin 1 type i overexpressing transgenic mice. NeuroReport. https://doi.org/10.1097/WNR.0b013e328330f6e7
Article PubMed PubMed Central Google Scholar
Dejaegere T, Serneels L, Schäfer MK et al (2008) Deficiency of Aph1B/C-γ-secretase disturbs Nrg1 cleavage and sensorimotor gating that can be reversed with antipsychotic treatment. Proc Natl Acad Sci USA. https://doi.org/10.1073/pnas.0800507105
Article PubMed PubMed Central Google Scholar
delPino I, García-Frigola C, Dehorter N et al (2013) Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes. Neuron. https://doi.org/10.1016/j.neuron.2013.07.010
El Iskandrani KS, Oosterhof CA, El Mansari M, Blier P (2015) Impact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: an in vivo electrophysiological study on monoaminergic and glutamatergic neurons. J Psychopharmacol. https://doi.org/10.1177/0269881115573809
Article PubMed PubMed Central Google Scholar
Ennaceur A, Delacour J (1988) A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav Brain Res. https://doi.org/10.1016/0166-4328(88)90157-X
Enriquez-Barreto L, Morales M (2016) The PI3K signaling pathway as a pharmacological target in Autism related disorders and Schizophrenia. Mol and Cell Ther 4:2. https://doi.org/10.1186/s40591-016-0047-9
Fortin DA, Srivastava T, Soderling TR (2012) Structural modulation of dendritic spines during synaptic plasticity. Neuroscientist 18(4):326–341
Gama CS, Canever L, Panizzutti B et al (2012) Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia. Schizophr Res. https://doi.org/10.1016/j.schres.2012.08.002
Georgiadou G, Grivas V, Tarantilis PA, Pitsikas N (2014) Crocins, the active constituents of Crocus Sativus L., counteracted ketamine-induced behavioural deficits in rats. Psychopharmacology (Berl). https://doi.org/10.1007/s00213-013-3293-4
Glausier JR, Fish KN, Lewis DA (2014) Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects. Mol Psychiatry. https://doi.org/10.1038/mp.2013.152
Grieco SF, Qiao X, Johnston KG et al (2021) Neuregulin signaling mediates the acute and sustained antidepressant effects of subanesthetic ketamine. Transl Psychiatry. https://doi.org/10.1038/s41398-021-01255-4
Article PubMed PubMed Central Google Scholar
Gu Z, Jiang Q, Fu AKY et al (2005) Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J Neurosci. https://doi.org/10.1523/JNEUROSCI.1086-05.2005
Article PubMed PubMed Central Google Scholar
Gupta S, Masand P (2004) Aripiprazole: Review of its pharmacology and therapeutic use in psychiatric disorders. Ann Clin Psychiatry. https://doi.org/10.1080/10401230490487007
Hahn CG, Wang HY, Cho DS et al (2006) Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med. https://doi.org/10.1038/nm1418
Harvey PD, Keefe RSE (2001) Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. Am J Psychiatry 158(2):176–184
Hasan A, Roeh A, Leucht S et al (2020) Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial. Contemp Clin Trials Commun. https://doi.org/10.1016/j.conctc.2020.100537
Article PubMed PubMed Central Google Scholar
Hashimoto R, Straub RE, Weickert CS et al (2004) Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry. https://doi.org/10.1038/sj.mp.4001434
Hereta M, Kamińska K, Białoń M et al (2020) Effect of combined treatment with aripiprazole and antidepressants on the MK-801-induced deficits in recognition memory in novel recognition test and on the release of monoamines in the rat frontal cortex. Behav Brain Res. https://doi.org/10.1016/j.bbr.2020.112769
Hoftman GD, Volk DW, Bazmi HH et al (2015) Altered cortical expression of GABA-related genes in schizophrenia: Illness progression vs developmental disturbance. Schizophr Bull. https://doi.org/10.1093/schbul/sbt178
Hongyan L, Chunyan W, Yue’e Y, (2017) LY294002, a PI3K inhibitor, attenuates Tourette syndrome in rats. Metab Brain Dis. https://doi.org/10.1007/s11011-017-0051-z
Hou Y, Xie J, Yuan Y et al (2020) Neurocognitive effects of atypical antipsychotics in patients with first-episode schizophrenia. Nord J Psychiatry. https://doi.org/10.1080/08039488.2020.1771767
Ibrahim WW, Sayed RH, Kandil EA, Wadie W (2022) Niacin mitigates blood–brain barrier tight junctional proteins dysregulation and cerebral inflammation in ketamine rat model of psychosis: role of GPR109A receptor. Prog Neuro-Psychopharmacology Biol Psychiatry 119:110583. https://doi.org/10.1016/j.pnpbp.2022.110583
Idris N, Neill J, Grayson B et al (2010) Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms. Psychopharmacology 208:23–36. https://doi.org/10.1007/s00213-009-1702-5
CAS Article PubMed Google Scholar
Janardhanan A, Sadanand A, Vanisree AJ (2017) Nardostachys jatamansi Targets BDNF-TrkB to Alleviate Ketamine-Induced Schizophrenia-Like Symptoms in Rats. Neuropsychobiology. https://doi.org/10.1159/000454985
Kandratavicius L, Balista PA, Wolf DC et al (2015) Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia. BMC Neurosci. https://doi.org/10.1186/s12868-015-0149-3
留言 (0)